Skip to main content

Table 3 Summary of articles discussing IL-1 beta and glutamate

From: Investigating the role of interleukin-1 beta and glutamate in inflammatory bowel disease and epilepsy using discovery browsing

Study

Subjects

Method

Result/Conclusion

Xiaoqin et al. [54]

Cerebral cortex and hippocampus of rats

Injection of IL-1 beta and IL-6; immuno-histochemistry

Increased glutamate and decreased GABA observed

Donnelly et al. [55]

Synaptosome pellets prepared from brains of 8-12 week-old BALB/c female mice intoxicated with glycerol

In vitro techniques

Report increased IL-1 beta levels and decreased glutamate release in hippocampus tissue

Hu et al. [56]

Human astrocyte cultures subjected to several cytokines and 3H-glutamate

Northern blot analysis and other in vitro techniques

Proinflammatory cytokines inhibit astrocyte glutamate uptake

Huang et al. [57]

Intracerebroventricular injection of IL-1beta in adult male New Zealand white rabbits

Intracerebral microdialysis

Glutamate induced by IL-1 beta

Mascarucci et al. [58]

Intraperitoneal injection of IL-1 beta in freely moving male Sprague–Dawley rats

Brain microdialysis

Increased glutamate released in the nucleus tractus solitarius

Murray et al. [59]

Synaptosomes prepared from male Wistar rats

Immunoblotting with specific antibody

IL-1 beta inhibits potassium chloride-stimulated glutamate release in tissue from young (4 month), in the presence of calcium

Gonzalez et al. [60]

Adult male Wistar rats

Intrahippocampal injection of IL-1 beta; preparation of synaptosomes; in vitro technique to assay glutamate release

IL-1 beta decreases glutamate release from dorsal hippocampus synaptosomes after contextual fear conditioning

  1. The query which retrieved the first two studies used the term “brain”, and that which retrieved the other studies used the term “epilepsy”)